Clinical relevance of pharmacokinetic and pharmacodynamic profiles of insulin degludec (100, 200 U/mL) and insulin glargine (100, 300 U/mL) – a review of evidence and clinical interpretation-Reference-Cited by-同舟云学术

Clinical relevance of pharmacokinetic and pharmacodynamic profiles of insulin degludec (100, 200 U/mL) and insulin glargine (100, 300 U/mL) – a review of evidence and clinical interpretation

Published:2019-09 Issue:4 Volume:45 Page:330-340
ISSN:1262-3636
Container-title:Diabetes & Metabolism
language:en
Short-container-title:Diabetes & Metabolism

Author:

Owens D.R.,S Bailey T.,Fanelli C.G.,Yale J.-F.,Bolli G.B.

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference59 articles.

1. Glucose counterregulation during prolonged hypoglycemia in normal humans;Boll;Am J Physiol,1984

2. Fluctuation of serum basal insulin levels following single and multiple dosing of insulin glargine;Gerich;Diabetes Technol Ther,2006

3. The future of basal insulin;Shah;Diabetes Technol Ther,2013

4. Variability of glucose-lowering effect as a limiting factor in optimizing basal insulin therapy: a review;Vora;Diabetes Obes Metab,2013

5. Pharmacokinetics and pharmacodynamics of insulin glargine given in the evening as compared with in the morning in type 2 diabetes;Porcellati;Diabetes Care,2015

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment intensification following glucagon-like peptide-1 receptor agonist in type 2 diabetes: Comparative effectiveness analyses between free vs. fixed combination of GLP-1 RA and basal insulin. RESTORE-G real-world study;Nutrition, Metabolism and Cardiovascular Diseases;2024-08

2. Nocturnal Glucose Profile According to Timing of Dinner Rapid Insulin and Basal and Rapid Insulin Type: An Insulclock® Connected Insulin Cap-Based Real-World Study;Biomedicines;2024-07-18

3. Effect of switching from twice-daily basal insulin to once-daily insulin glargine 300 U/mL (Gla-300) in Brazilian people with type 1 diabetes;Diabetology & Metabolic Syndrome;2024-07-09

4. Treatment intensification following glucagon‐like peptide‐1 receptor agonists in type 2 diabetes: Comparative effectiveness analyses between different basal insulins. RESTORE‐G real‐world study;Diabetes, Obesity and Metabolism;2024-06-10

5. A dose titration protocol for once‐daily insulin glargine 300 U/mL for the treatment of diabetes mellitus in dogs;Journal of Veterinary Internal Medicine;2024-06-03